1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors

Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors

  • August 2013
  • -
  • La Merie Publishing
  • -
  • 17 pages

Summary

Table of Contents

Search Inside

Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors

Product description

The present Competitive Intelligence report about Anaplastic Lymphoma Kinase (ALK) Inhibitors provides a competitor evaluation in the field of small molecule and antibody-based inhibitors of Anaplastic Lymphoma Kinase (ALK) for the treatment of solid tumors as of August 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of selective and dual target small molecule Anaplastic Lymphoma Kinase (ALK) inhibitors and of antibody-based ALK inhibitors in oncology. In addition, the report lists company-specific R&D pipelines of ALK inhibitors. Competitor projects are listed in a tabular format providing information on:

- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.


About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Non-Hodgkin Lymphoma Forecast in 18 Major Markets 2017-2027

Epiomic Epidemiology Series: Non-Hodgkin Lymphoma Forecast in 18 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • February 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Non-Hodgkin Lymphoma in 18 Major Markets Non-Hodgkin Lymphomas (NHL) are a diverse group of blood cancers that develop from lymphocytes ...

Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market  Forecast-2023

Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

Hodgkin’s lymphoma (HL) - Market Insights, Epidemiology and Market Forecast-2023

Hodgkin’s lymphoma (HL) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Hodgkin’s lymphoma (HL) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Hodgkin’s lymphoma (HL) ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the Netherlands - Forecast

  • April 2017
    10 pages
  • Cancer  

  • Netherlands  

View report >

Endocrine Disease Statistics in the US

  • April 2017
    122 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Lung Cancer Statistics in Europe - Forecast

  • April 2017
    10 pages
  • Lung Cancer  

    Therapy  

  • Europe  

View report >

Leukemia Statistics

19 days ago

Related Market Segments :

Lymphoma

ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.